Skip to main content
logo
Titan Pharmaceuticals, Inc. (TTNP)
Oct 2, 2025 - TTNP was delisted (reason: merged into BTTC).
4.610
-0.180 (-3.76%)
Inactive · Last trade price on Oct 1, 2025

Titan Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
--0.180.561.534.84
Revenue Growth
---66.97%-63.50%-68.46%85.72%
Gross Profit
---1.73-4.2-4.37-1.55
Operating Income
-2.61-4.56-7.28-10.24-9.35-7.35
Net Income
-2.81-4.71-5.57-10.21-8.78-18.24
Earnings Per Share
-2.95-5.23-7.41-15.19-18.04-96.70
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
2.82.836.762.946.045.41
Total Debt
--0.570.190.30.81
Net Cash (Debt)
2.82.836.22.755.744.6
Net Cash Growth
-31.50%-54.30%125.27%-52.07%24.63%488.75%
Net Cash Per Share
2.943.158.244.0911.7924.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-2.75-3.88-7.09-8.18-7.9-17.2
Capital Expenditures
---0--0.02-0.54
Free Cash Flow
-2.75-3.88-7.09-8.18-7.92-17.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
-----286.04%-32.04%
Operating Margin
---3954.89%-1837.52%-612.97%-151.94%
Pretax Margin
---3026.63%-1832.32%-575.10%-153.10%
Profit Margin
---3026.63%-1832.32%-575.10%-377.06%
FCF Margin
---3855.43%-1469.12%-519.13%-366.74%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
--33.7820.576.634.81